2 Commercially available GLP-1 receptor agonists (GLP-1RA) include dulaglutide, exenatide, semaglutide, the dual GLP-1 and gastric inhibitory polypeptide receptor agonist tirzepatide, and combined liraglutide/insulin degludec and lixisenatide/insulin glargine
This guide covers everything researchers need to know about GHK-CU injection protocols
DC analyzed and interpreted the fMRI data and contributed to the writing of the manuscript
Appetite suppression and early satiety induced by GLP-1 receptor agonists can lead to reduced caloric and protein intake, increasing the risk of micronutrient deficiencies (notably vitamin D, B12, calcium, iron, magnesium, and zinc) and sarcopenia, especially during rapid or substantial weight loss